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June 21, 2011:2542–6The current literature consistently demonstrates that CCTA
has significant prognostic usefulness; however, because of the
highlighted limitations to the available published data, additional
studies that include longer follow-up durations and detailed
outcome reporting will further clarify the prognostic test parame-
ters of CCTA.
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Alcohol Consumption
and Risk of Atrial Fibrillation
We read with interest the meta-analysis on alcohol consumption
and risk of atrial fibrillation (AF) by Kodama and coworkers (1).
owever, several characteristics of our prior publication that are
entioned in Table 1 of the meta-analysis are in need of
larification (2). First, the Women’s Health Study is a prospective
ohort study among female health professionals in the United
tates, not Switzerland (3). Second, the predominant AF pattern
n the Women’s Health Study is actually paroxysmal AF, not
hronic AF, with about two-thirds of the participants with
ew-onset AF having paroxysmal AF. Third, AF diagnosis was
ot based on participants’ reports, but all cases were confirmed by
edical record review. Based on these corrections, the analyses
tratified by these variables presented in Table 2 should be
odified.
In addition, we would like to suggest an additional analysis for
he authors’ consideration. Although sex did not modify the
elationship between alcohol and AF when the results comparing
xtremes of intake were combined in Table 2, the extreme levels of
lcohol intake were generally lower among women as compared
ith men in these studies. Indeed, prior studies have suggested
hat the level of alcohol intake at which AF risk elevates may be
ubstantially lower among women (about 2 drinks per day) as
ompared with men (about 4 to 5 drinks per day) (2,4,5).Therefore, it would be of interest to see the dose-response
relationship between alcohol consumption and AF risk presented
in Figure 4 stratified by sex.
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Reply
We appreciate Drs. Conen and Albert pointing out data that were
mistakenly extracted from their study (1) in our meta-analysis of
the relationship between alcohol consumption and risk of atrial
fibrillation (AF) (2). We apologize. As a result, we carefully
rechecked all data from all papers included in our meta-analysis. In
addition, we found that, more precisely, AF was ascertained by
electrocardiogram rather than from medical records in the study by
Cohen et al. (3). Also, studies initially cited as conducted in
Sweden by Ruigomez et al. (4,5) were performed in the United
Kingdom.
After correcting these data, we reconducted the stratified
analyses of pooled relative risk of AF for highest alcohol intake
versus lowest alcohol intake according to study characteristics.
Nonsignificant differences in AF risk were observed by geographic
region (1.38 [95% confidence interval (CI): 1.22 to 1.56] in North
America and 1.51 [95% CI: 1.23 to 1.86] in Europe; p  0.85) or
by the dominant AF type (1.42 [95% CI: 1.22 to 1.66] for chronic
AF and 1.78 [95% CI: 1.43 to 2.22] for paroxysmal AF; p 0.11).
When AF was ascertained by medical records, the AF risk was
larger (2.05 [95% CI: 1.20 to 3.53]) than by other methods (1.48
[95% CI: 1.29 to 1.70]), but was without statistical significance
(p  0.34). In total, the influences of the corrections were very
slight.
We agree that it would be desirable to investigate the dose-
response relationship between alcohol consumption and AF risk
with stratification by sex, considering that the level of alcohol
intake at which AF risk elevates may be substantially lower among
women than among men (1). However, the number of eligible
studies for a dose-response analysis is too few (n  9) for such an
investigation. This point might have been addressed as a study
